Bergamot oil
CAS 8007-75-8
Bergamot oil (CAS 8007-75-8) is a pharmaceutical compound with 0 bioactivity targets and 2 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Bergamot oil is linked to DTXSID8034378 in DSSTox identifiers.
View industrial chemical data →Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| BERGAMOT OIL | 1305651 | SU | MTHSPL |
| bergamot oil | 1305651 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Bergamot oil used for in pharmaceutical contexts?
Bergamot oil (CAS 8007-75-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Bergamot oil?
Bergamot oil has 2 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Death, Influenza like illness. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Bergamot oil also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Citrus Aurantium Bergamia Fruit Oil with EU status "restricted".
What clinical phase is Bergamot oil in?
No phase 1-4 clinical development badge is rendered for Bergamot oil because the matched compound identifier rows do not contain a max-phase value.